EX-12 8 c47344exv12.htm EX-12 exv12
EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Unaudited)
Eli Lilly and Company and Subsidiaries
(Dollars in millions)
                                                 
    Nine Months    
    Ended    
    September 30,   Years Ended December 31,
    2008   2007   2006   2005   2004   2003
     
 
                                                
Consolidated pretax income before cumulative effect of a change in accounting principle
  $ 2,029.8     $ 3,876.8     $ 3,418.0     $ 2,717.5     $ 2,941.9     $ 3,261.7  
 
                                                
Interest1
    185.4       322.5       344.8       245.7       162.9       121.9  
 
                                                
Less interest capitalized during the period
    (39.0 )     (94.2 )     (106.7 )     (140.5 )     (111.3 )     (60.9 )
     
 
                                                
Earnings
  $ 2,176.2     $ 4,105.1     $ 3,656.1     $ 2,822.7     $ 2,993.5     $ 3,322.7  
     
 
                                                
Fixed charges
  $ 185.4     $ 322.5     $ 344.8     $ 245.7     $ 162.9     $ 121.9  
     
 
                                                
Ratio of earnings to fixed charges
    11.7       12.7       10.6       11.5       18.4       27.3  
     
 
1   Interest is based upon interest expense reported as such in the consolidated income statement and does not include any interest related to unrecognized tax benefits, which is included in income tax expense.